HL7 Czech Terminology Implementation Guide
0.3.0 - release
CZ
HL7 Czech Terminology Implementation Guide, published by HL7 Czech Republic. This guide is not an authorized publication; it is the continuous build for version 0.3.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7-cz/terminology/ and changes regularly. See the Directory of published versions
| Official URL: https://sukl.cz/terminology/ValueSet/dlp-atc | Version: 0.3.0 | ||||
| Standards status: Trial-use | Maturity Level: 2 | Computable Name: DLP_atc | |||
Value set of DLP ATC
References
Language: cs
https://sukl.cz/terminology/CodeSystem/dlp-atc version 📦0.3.0
Expansion performed internally based on codesystem ATC CZ v0.3.0 (CodeSystem)
This value set contains 91 concepts
| Level | System | Code | Display (cs) - Czech (cs) | JSON | XML |
| 1 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A | ALIMENTARY TRACT AND METABOLISM | ||
| 2 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01 | STOMATOLOGICAL PREPARATIONS | ||
| 3 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01A | STOMATOLOGICAL PREPARATIONS | ||
| 4 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AA | Caries prophylactic agents | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AA01 | sodium fluoride | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AA02 | sodium monofluorophosphate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AA03 | olaflur | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AA04 | stannous fluoride | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AA30 | combinations | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AA51 | sodium fluoride, combinations | ||
| 4 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB | Antiinfectives and antiseptics for local oral treatment | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB02 | hydrogen peroxide | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB03 | chlorhexidine | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB04 | amphotericin B | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB05 | polynoxylin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB06 | domiphen | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB07 | oxyquinoline | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB08 | neomycin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB09 | miconazole | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB10 | natamycin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB11 | various | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB12 | hexetidine | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB13 | tetracycline | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB14 | benzoxonium chloride | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB15 | tibezonium iodide | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB16 | mepartricin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB17 | metronidazole | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB18 | clotrimazole | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB19 | sodium perborate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB21 | chlortetracycline | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB22 | doxycycline | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB23 | minocycline | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB24 | octenidine | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB25 | oxytetracycline | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | A01AB53 | chlorhexidine and cetylpyridinium | ||
| 1 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C | CARDIOVASCULAR SYSTEM | ||
| 2 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10 | LIPID MODIFYING AGENTS | ||
| 3 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10A | LIPID MODIFYING AGENTS, PLAIN | ||
| 4 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA | HMG CoA reductase inhibitors | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA01 | simvastatin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA02 | lovastatin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA03 | pravastatin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA04 | fluvastatin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA05 | atorvastatin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA06 | cerivastatin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA07 | rosuvastatin | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AA08 | pitavastatin | ||
| 4 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB | Fibrates | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB01 | clofibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB02 | bezafibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB03 | aluminium clofibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB04 | gemfibrozil | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB05 | fenofibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB06 | simfibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB07 | ronifibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB08 | ciprofibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB09 | etofibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB10 | clofibride | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB11 | choline fenofibrate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AB12 | pemafibrate | ||
| 4 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AC | Bile acid sequestrants | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AC01 | colestyramine | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AC02 | colestipol | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AC03 | colextran | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AC04 | colesevelam | ||
| 4 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AD | Nicotinic acid and derivatives | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AD01 | niceritrol | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AD02 | nicotinic acid | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AD03 | nicofuranose | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AD04 | aluminium nicotinate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AD05 | nicotinyl alcohol (pyridylcarbinol) | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AD06 | acipimox | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AD52 | nicotinic acid, combinations | ||
| 4 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX | Other lipid modifying agents | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX01 | dextrothyroxine | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX02 | probucol | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX03 | tiadenol | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX05 | meglutol | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX06 | omega-3-triglycerides incl. other esters and acids | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX07 | magnesium pyridoxal 5-phosphate glutamate | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX08 | policosanol | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX09 | ezetimibe | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX10 | alipogene tiparvovec | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX11 | mipomersen | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX12 | lomitapide | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX13 | evolocumab | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX14 | alirocumab | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX15 | bempedoic acid | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX16 | inclisiran | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX17 | evinacumab | ||
| 5 | https://sukl.cz/terminology/CodeSystem/dlp-atc | C10AX18 | volanesorsen |